Ibudilast decreases progression of brain atrophy in progressive multiple sclerosis
A Phase II clinical trial of ibudilast has revealed that the drug decreases progression of brain atrophy in patients with progressive multiple sclerosis.
Browsing: ibudilast
NCTalks with Robert Fox: current landscape and potential treatment regimens for ibudilast in MS
Robert Fox chats to Lauren Pulling about ibudilast in progressive MS, including the current landscape and potential treatment regimens.
